This scrip has fully corrected, bottomed out and has made a double bottom. Now it is poised to rise, as its USA sales have become stabilised with low prices of generic medicine acceptable to them. Buy and hold on for reaping good benefits.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.